Reply to letter: “Limitations of complement activity assays as biomarkers for Ravulizumab therapeutic monitoring” by Saccà and Pelto Regarding “Inhibition of classical and alternative complement pathway by Ravulizumab and Eculizumab”
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Article (Journal) Editorial |
| Lingua: | inglese |
| Pubblicazione: |
2026
|
| In: |
Annals of Clinical and Translational Neurology
Year: 2026, Volume: 13, Fascicolo: 6, Pages: 1303-1304 |
| ISSN: | 2328-9503 |
| DOI: | 10.1002/acn3.70403 |
| Accesso online: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/acn3.70403 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/acn3.70403 
|
| Note sull'autore: | Lea Gerischer, Jutta Schroeder-Braunstein, Guido Wabnitz, Andreas Meisel |
| Descrizione del documento: | Gesehen am 10.06.2026 |
|---|---|
| Descrizione fisica: | Online Resource |
| ISSN: | 2328-9503 |
| DOI: | 10.1002/acn3.70403 |